Schonfeld Strategic Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-464,250
| Closed | -$866K | – | 2677 |
|
|
2025
Q3 | $866K | Buy |
464,250
+451,816
| +3,634% | +$44.8M | ﹤0.01% | 1450 |
|
|
2025
Q2 | $1.13M | Sell |
12,434
-344,968
| -97% | -$33.4M | 0.01% | 1250 |
|
|
2025
Q1 | $40.5M | Buy |
357,402
+353,962
| +10,290% | +$37.9M | 0.24% | 51 |
|
|
2024
Q4 | $363K | Sell |
3,440
-835
| -20% | -$89.6K | ﹤0.01% | 1535 |
|
|
2024
Q3 | $461K | Buy |
4,275
+158
| +4% | +$17.2K | ﹤0.01% | 1473 |
|
|
2024
Q2 | $447K | Buy |
+4,117
| New | +$485K | ﹤0.01% | 1533 |
|
|
2024
Q1 | – | Sell |
-58,244
| Closed | -$7.09M | – | 2469 |
|
|
2023
Q4 | $7.09M | Sell |
58,244
-61,746
| -51% | -$6.89M | 0.05% | 436 |
|
|
2023
Q3 | $13.5M | Buy |
119,990
+57,377
| +92% | +$7.29M | 0.1% | 276 |
|
|
2023
Q2 | $9.12M | Sell |
62,613
-41,277
| -40% | -$5.61M | 0.08% | 362 |
|
|
2023
Q1 | $13.4M | Buy |
103,890
+81,289
| +360% | +$10.2M | 0.13% | 226 |
|
|
2022
Q4 | $2.88M | Buy |
22,601
+9,623
| +74% | +$1.12M | 0.02% | 683 |
|
|
2022
Q3 | $1.36M | Sell |
12,978
-45,206
| -78% | -$4.96M | 0.01% | 1081 |
|
|
2022
Q2 | $6.11M | Sell |
58,184
-61,880
| -52% | -$7.34M | 0.06% | 413 |
|
|
2022
Q1 | $15.4M | Buy |
120,064
+2,988
| +3% | +$360K | 0.14% | 168 |
|
|
2021
Q4 | $14.4M | Buy |
+117,076
| New | +$15.3M | 0.13% | 208 |
|
|
2021
Q3 | – | Sell |
-238,487
| Closed | -$37.2M | – | 2520 |
|
|
2021
Q2 | $37.2M | Buy |
238,487
+111,663
| +88% | +$18.1M | 0.4% | 33 |
|
|
2021
Q1 | $19.7M | Buy |
126,824
+22,514
| +22% | +$3.49M | 0.24% | 99 |
|
|
2020
Q4 | $15.6M | Buy |
+104,310
| New | +$14.7M | 0.21% | 113 |
|
|
2020
Q3 | – | Sell |
-9,756
| Closed | -$1.13M | – | 1715 |
|
|
2020
Q2 | $1.13M | Sell |
9,756
-6,091
| -38% | -$702K | 0.03% | 573 |
|
|
2020
Q1 | $1.55M | Sell |
15,847
-48,382
| -75% | -$6.34M | 0.1% | 250 |
|
|
2019
Q4 | $9.33M | Sell |
64,229
-53,920
| -46% | -$7.44M | 0.23% | 117 |
|
|
2019
Q3 | $15.7M | Buy |
118,149
+103,317
| +697% | +$13.3M | 0.46% | 53 |
|
|
2019
Q2 | $1.58M | Sell |
14,832
-20,291
| -58% | -$2.38M | 0.06% | 342 |
|
|
2019
Q1 | $4.36M | Sell |
35,123
-13,499
| -28% | -$1.53M | 0.15% | 180 |
|
|
2018
Q4 | $4.9M | Buy |
+48,622
| New | +$5.47M | 0.19% | 151 |
|
|
2017
Q2 | – | Sell |
-4,988
| Closed | -$591K | – | 793 |
|
|
2017
Q1 | $591K | Buy |
+4,988
| New | +$565K | 0.06% | 342 |
|
Other funds holding ZBH
Schonfeld Strategic Advisors's ZBH Position: Q4 2025 in Review
Schonfeld Strategic Advisors sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 464,250 shares — an estimated $866K sold.
Schonfeld Strategic Advisors first reported a position in ZBH in Q1 2017 and held it in 26 quarters. The position peaked at $40.5M in Q1 2025. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.
- Schonfeld Strategic Advisors reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 464,250 Zimmer Biomet shares in Q4 2025, an estimated $866K.
- Schonfeld Strategic Advisors first reported a position in Zimmer Biomet in Q1 2017 and held it in 26 quarters.
- Schonfeld Strategic Advisors's Zimmer Biomet position peaked at $40.5M in Q1 2025.
- 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.